Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome
TNThe National Heart, Lung, and Blood Institute PETAL Clinical Trials Network
Indexed incrossrefpubmed
Abstract
Background
The benefits of early continuous neuromuscular blockade in patients with acute respiratory distress syndrome (ARDS) who are receiving mechanical ventilation remain unclear.
Methods
We randomly assigned patients with moderate-to-severe ARDS (defined by a ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen of
Citation impact
872
total citations
- FWCI
- 89.21
- Percentile
- 100%
- References
- 47
Citations per year
Authors
1- TNThe National Heart, Lung, and Blood Institute PETAL Clinical Trials NetworkCorresponding
Topics & keywords
Topics
Keywords
- Neuromuscular Blockade
- ARDS
- Acute respiratory distress
- Blockade
- Medicine
- Mechanical ventilation
- Respiratory distress
- Anesthesia
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- UDU.S. Department of Veterans Affairs
- GGlaxoSmithKline
- UTUnited Therapeutics Corporation
- NHNational Heart, Lung, and Blood InstituteAwards: U01HL123022, U01HL123010, U01HL123033, U01HL122989, U01HL123022, U01HL123009, U01HL122998, U01HL123033, U01HL123008, U01HL123031, U01HL123004, U01HL123027, U01HL123004, U01HL123023, U01HL123031, U01HL123008, U01HL123009, U01HL122998, U01HL123018, U01HL123023, U01HL123010, U01HL123018, U01HL123027, U01HL122989, U01HL123020
- APActelion Pharmaceuticals